Objective: To review systematically data relating to weight changes with atypical
antipsychotics. Method: We conducted a Medline search on October 29 1999 and covered …

BACKGROUND: The co-occurrence of bipolar and eating disorders, though of major clinical
and public health importance, remains relatively unexamined. METHODS: In reviewing the …

OBJECTIVE: The authors discuss changes in body weight associated with various
psychopharmaceuticals. METHODS: A large number of articles and books about drug …

Objective: We reviewed available pediatric literature on second-generation antipsychotic
medications to assess current evidence of efficacy and safety. Method: An English language …

Objectives: To review the scientific evidence examining the comorbidity among eating
disorders and bipolar disorder (BD). Methods: We reviewed all published English‐language …

This paper reviews past and current progress in developing pharmacologic agents for the
treatment of individuals with bulimia nervosa (BN). We searched the literature and clinical …

Objective: There has been much interest in the use of atypical antipsychotics in anorexia
nervosa (AN). However, newer, more weight‐neutral medications have not been studied in …

Objective. To explore the association between eating disorders (EDs) prior to the use of
clozapine/olanzapine (pre-clozapine/olanzapine EDs) and after initiation of these …

Antipsychotics are medications that reduce the symptoms of hallucinations and delusions
that characterize psychosis. They have been used in the treatment of patients with …

Background: Given growing concern about weight gain associated with treatment with
antipsychotic agents, we performed a retrospective chart review of patients who reversed …